trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Retinoblastoma D012175 12 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leishmaniasis D007896 19 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Translocation, Genetic D014178 20 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Fibrosis D005355 23 associated lipids
Breast Neoplasms D001943 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Glioblastoma D005909 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kikuno N et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. 2008 Int. J. Cancer pmid:18431742
Zhang HJ et al. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. 2008 Placenta pmid:18440631
Xu LN et al. Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines. 2008 World J. Gastroenterol. pmid:18442209
Yu C et al. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. 2008 Neuro-oncology pmid:18445700
Jensen TJ et al. Epigenetic remodeling during arsenical-induced malignant transformation. 2008 Carcinogenesis pmid:18448484
van West P et al. Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. 2008 Microbiology (Reading, Engl.) pmid:18451057
Geli J et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. 2008 Int. J. Cancer pmid:18452173
Moynihan AT et al. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. 2008 Am. J. Obstet. Gynecol. pmid:18455134
Mackay CL et al. Sensitive, specific, and quantitative FTICR mass spectrometry of combinatorial post-translational modifications in intact histone H4. 2008 Anal. Chem. pmid:18457408
Hishikawa K and Fujita T [Kidney regeneration update]. 2008 Nippon Rinsho pmid:18464514
Dalgard CL et al. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. 2008 Clin. Cancer Res. pmid:18483379
Egler V et al. Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death. 2008 Clin. Cancer Res. pmid:18483381
Chu F et al. Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. 2008 Aging Cell pmid:18489729
Chen Y et al. A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. 2008 J. Med. Chem. pmid:18494463
Sun C and Zhou J Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. 2008 Biochem. Pharmacol. pmid:18495085
Ma P and Schultz RM Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. 2008 Dev. Biol. pmid:18501342
Cao W et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. 2008 J. Exp. Med. pmid:18504304
Pan J et al. TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells. 2008 Mol. Cancer Res. pmid:18505930
Hou J et al. Epigenetic modification of histone 3 at lysine 9 in sheep zygotes and its relationship with DNA methylation. 2008 BMC Dev. Biol. pmid:18507869
Chung KS et al. Fission yeast-based screening to identify putative HDAC inhibitors using a telomeric reporter strain. 2008 Mol. Cells pmid:18525239
Makki MS et al. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. 2008 Nucleic Acids Res. pmid:18535006
Hoffmann K et al. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? 2008 Epilepsy Res. pmid:18538545
Jiang X et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. 2008 Cancer Cell pmid:18538736
Gavin DP et al. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. 2008 Schizophr. Res. pmid:18539439
Lecona E et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. 2008 Mol. Cell. Biol. pmid:18541673
Marengo E et al. Evaluation of the variables characterized by significant discriminating power in the application of SIMCA classification method to proteomic studies. 2008 J. Proteome Res. pmid:18543959
Zhu X et al. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. 2008 J. Clin. Endocrinol. Metab. pmid:18544619
Gaviraghi M et al. Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene. 2008 BMC Mol. Biol. pmid:18549468
Mühlethaler-Mottet A et al. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. 2008 Mol. Cancer pmid:18549473
Kim B et al. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. 2008 Eur. J. Pharmacol. pmid:18550052
Tavera-Mendoza LE et al. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18550844
Chan DW et al. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. 2008 Int. J. Cancer pmid:18553387
Ding X et al. Increased pre-implantation development of cloned bovine embryos treated with 5-aza-2'-deoxycytidine and trichostatin A. 2008 Theriogenology pmid:18556056
Jia J and Chen J Histone hyperacetylation is involved in the quercetin-induced human leukemia cell death. 2008 Pharmazie pmid:18557424
Muscolini M et al. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells. 2008 Mol. Cancer Ther. pmid:18566213
Bieliauskas AV and Pflum MK Isoform-selective histone deacetylase inhibitors. 2008 Chem Soc Rev pmid:18568166
Li J et al. High in vitro development after somatic cell nuclear transfer and trichostatin A treatment of reconstructed porcine embryos. 2008 Theriogenology pmid:18573521
Liu Z et al. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. 2008 Oncol. Rep. pmid:18575731
Plouffe D et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18579783
Sun Y et al. Modulation of transcription parameters in glucocorticoid receptor-mediated repression. 2008 Mol. Cell. Endocrinol. pmid:18583028
Ree AH et al. HDAC2 deficiency and histone acetylation. 2008 Nat. Genet. pmid:18583969
Liu Y et al. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. 2008 Cancer Invest. pmid:18584348
Kato A et al. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. 2008 Exp. Cell Res. pmid:18588874
Chen CJ et al. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells. 2008 Eur. J. Pharmacol. pmid:18590721
Zhang Y et al. Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release. 2008 J. Biol. Chem. pmid:18596044
Łuczak MW and Jagodziński PP Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells. 2009 Biomed. Pharmacother. pmid:18602794
Northrop JK et al. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. 2008 J. Immunol. pmid:18606637
Schmeck B et al. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. 2008 J. Immunol. pmid:18606645
Miyanaga A et al. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model. 2008 Mol. Cancer Ther. pmid:18606719
Tischler JL et al. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors. 2008 J Enzyme Inhib Med Chem pmid:18608778
Auer D et al. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. 2009 Breast Cancer Res. Treat. pmid:18618240
Hayakawa F et al. Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 2008 J. Biol. Chem. pmid:18621739
Wu JY et al. Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. 2008 Neuroreport pmid:18628666
Shakèd M et al. Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. 2008 PLoS ONE pmid:18628975
Kawamura T et al. Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts. 2009 Dig. Dis. Sci. pmid:18629644
Fontán-Lozano A et al. Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. 2008 Mol. Cell. Neurosci. pmid:18638560
Fabre C et al. A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. 2008 Cell Cycle pmid:18641459
Kozikowski AP et al. Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. 2008 J. Med. Chem. pmid:18642892
Dow GS et al. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. 2008 Antimicrob. Agents Chemother. pmid:18644969
Liu PY et al. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. 2008 Mol. Cancer Res. pmid:18644983
Roy S et al. Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells. 2008 Mol. Cancer Ther. pmid:18645003
Reilly CM et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. 2008 J. Autoimmun. pmid:18650065
Law AY et al. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. 2008 Exp. Cell Res. pmid:18652825
Nishikiori N et al. Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. 2008 May-Jun Jpn. J. Ophthalmol. pmid:18661270
Narver HL et al. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. 2008 Ann. Neurol. pmid:18661558
Peng DF et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. 2009 Gut pmid:18664505
Yu J et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. 2008 Hepatology pmid:18666234
Lee TB et al. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy. 2008 BMC Gastroenterol pmid:18673531
Xiang N et al. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. 2008 Carcinogenesis pmid:18676679
Duan H et al. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. 2008 Oncogene pmid:18695675
Iacobazzi V et al. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. 2008 Biochem. Biophys. Res. Commun. pmid:18706393
Falk M et al. Chromatin structure influences the sensitivity of DNA to gamma-radiation. 2008 Biochim. Biophys. Acta pmid:18706456
Zhang XH et al. Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer. 2008 Cancer Biol. Ther. pmid:18708766
Lu MC et al. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. 2009 Arch. Toxicol. pmid:18709356
Yang YN et al. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells]. 2008 Ai Zheng pmid:18710614
Obrdlik A et al. The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription. 2008 Mol. Cell. Biol. pmid:18710935
Haumaitre C et al. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. 2008 Mol. Cell. Biol. pmid:18710955
Yang L et al. [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro]. 2008 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:18718068
Zou XM et al. Gastric cancer cell lines induced by trichostatin A. 2008 World J. Gastroenterol. pmid:18720545
Miyoshi M et al. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. 2008 Nov-Dec Nutrition pmid:18723323
Codd R et al. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. 2009 Int. J. Biochem. Cell Biol. pmid:18725319
Kim M et al. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. 2008 Cancer Res. pmid:18757430
Ma Y et al. Inhibition of protein deacetylation by trichostatin A impairs microtubule-kinetochore attachment. 2008 Cell. Mol. Life Sci. pmid:18759129
Bosisio D et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. 2008 J. Leukoc. Biol. pmid:18780875
Li M et al. Upregulation of human with-no-lysine kinase-4 gene expression by GATA-1 acetylation. 2009 Int. J. Biochem. Cell Biol. pmid:18793746
Björkman M et al. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. 2008 Int. J. Cancer pmid:18798265
Romieu P et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. 2008 J. Neurosci. pmid:18799668
Yoshioka H et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. 2008 J. Biol. Chem. pmid:18801729
Bonazzi VF et al. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. 2009 Genes Chromosomes Cancer pmid:18803327
Lee EJ et al. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. 2008 Int. J. Oncol. pmid:18813790
Van Wagoner DR and Nattel S Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. 2008 J. Mol. Cell. Cardiol. pmid:18817781
Hoebeeck J et al. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. 2009 Cancer Lett. pmid:18819746
Han JQ et al. [Effects of trichostatin A on the interaction between HBx and histone deacetylase protein 1]. 2008 Zhonghua Gan Zang Bing Za Zhi pmid:18822204
Fraczek J et al. Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. 2009 Invest New Drugs pmid:18825314
Pellicciotta I et al. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. 2008 Cancer Res. pmid:18829567
Demircan B et al. Comparative epigenomics of human and mouse mammary tumors. 2009 Genes Chromosomes Cancer pmid:18836996
Smetana K et al. To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. 2008 Jul-Sep Eur J Histochem pmid:18840553
Hitchler MJ et al. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. 2008 Free Radic. Biol. Med. pmid:18845242
Lee SH et al. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. 2009 Oncogene pmid:18850007
Wu X et al. Trichostatin A improved epigenetic modifications of transfected cells but did not improve subsequent cloned embryo development. 2008 Anim. Biotechnol. pmid:18855246